MAD1L1 anticorps (N-Term)

N° du produit ABIN656281

Cet anticorps Lapin Polyclonal détecte spécifiquement MAD1L1 dans WB. Il présente une réactivité envers Humain.

Aperçu rapide pour MAD1L1 anticorps (N-Term) (ABIN656281)

Antigène: MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MAD1L1 est non-conjugé

Application: Western Blotting (WB)

Clone: RB20598

Détail du produit anti-MAD1L1 anticorps

Épitope: AA 124-151, N-Term

Purification: This antibody is purified through a protein A column, followed by peptide affinity purification.

Immunogène: This MAD1L1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 124-151 amino acids from the N-terminal region of human MAD1L1.

Isotype: Ig Fraction

Information d'application

Indications d'application: WB: 1:1000

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Stock: 4 °C,-20 °C

Stockage commentaire: MAD1L1 Antibody (N-term) can be refrigerated at 2-8 °C for up to 6 months. For long term storage, place the at -20 °C.

Date de péremption: 6 months

Détails sur MAD1L1

Antigène: MAD1L1 (MAD1 Mitotic Arrest Deficient-Like 1 (MAD1L1))

Autre désignation: MAD1L1

Sujet: MAD1L1 is a component of the mitotic spindle-assembly checkpoint that prevents the onset of anaphase until all chromosome are properly aligned at the metaphase plate. MAD1L1 functions as a homodimer and interacts with MAD2L1. MAD1L1 may play a role in cell cycle control and tumor suppression. Three transcript variants encoding the same protein have been found for this gene. [provided by RefSeq].

Poids moléculaire: 83067

ID gène: 8379

NCBI Accession: NP_001013858, NP_001013859, NP_003541

UniProt: Q9Y6D9

Pathways: M Phase